Reaction
Haematocrit Abnormal reporting signals
As of the last recalculation, Haematocrit Abnormal appears in 1,220 FAERS reports alongside 15 co-occurring drug terms. The strongest observed disproportionality signal is RUXOLITINIB (PRR 102.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ruxolitinib | 318 | 102.0 | 102.5 |
| Eculizumab | 116 | 40.1 | 40.2 |
| Erythropoietin | 35 | 29.9 | 29.9 |
| Epoetin Alfa | 19 | 27.8 | 27.8 |
| Hydroxyurea | 32 | 26.5 | 26.5 |
| Febuxostat Tablets 40 Mg | 13 | 22.0 | 22.1 |
| Febuxostat Tablets 80 Mg | 13 | 22.0 | 22.1 |
| Febuxostat | 14 | 14.4 | 14.4 |
| Ribociclib | 24 | 13.2 | 13.2 |
| Avapritinib | 7 | 9.9 | 9.9 |
| Olaparib | 11 | 9.0 | 9.0 |
| Pazopanib Hydrochloride | 13 | 8.3 | 8.3 |
| Voxelotor | 9 | 6.9 | 6.9 |
| Sevelamer Carbonate | 4 | 6.0 | 6.0 |
| Acalabrutinib | 4 | 5.6 | 5.6 |